| MR编号 | NL/H/4565/001 |
|---|
| 药品名称 | lrinotecan Hydrochloride Trihydrate 20 mg/ml, |
|---|
| 活性成分 | - irinotecan hydrochloride 3 H<2>O 20.0 mg/ml
|
|---|
| 剂型 | Concentrate for solution for infusion |
|---|
| 上市许可持有人 | Accord Healthcare Limited. Sage House. 319 Pinner Road. Not1h Harrow. Middlesex.
HA I 4HF, UK. |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) |
|---|
| 互认成员国 - 产品名称 | - United Kingdom (Northern Ireland) (XI)
- Germany (DE)
Irinotecan Accord 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung - Denmark (DK)
Irinotecan Accord - Belgium (BE)
Irinotecan Accord 20 mg/ml Solution à diluer pour perfusion - Iceland (IS)
Irinotecan Accord 20 mg/ml Innrennslisþykkni, lausn - Ireland (IE)
- Austria (AT)
Irinotecan Accord 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung - France (FR)
- Spain (ES)
- Luxembourg (LU)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
IRINOTECAN/ACCORD - Sweden (SE)
- Norway (NO)
Irinotecan Accord - Finland (FI)
- Poland (PL)
Irinotecan Accord - Latvia (LV)
Irinotecan Accord 20 mg/ml koncentrāts infūziju šķīduma pagatavošanai - Lithuania (LT)
Irinotecan Accord 20 mg/ml koncentratas infuziniam tirpalui - Estonia (EE)
IRINOTECAN ACCORD - Hungary (HU)
IRINOTECAN ACCORD 20 mg/ml koncentrátum oldatos infúzióhoz - Bulgaria (BG)
Irinotecan Accord - Cyprus (CY)
- Czechia (CZ)
Irinotecan Accordpharma 20 mg/ml koncentrát pro infuzní roztok - Romania (RO)
Irinotecan Accord 20 mg/ml concentrat pentru soluţie perfuzabilă - Slovakia (SK)
Irinotecan Accord 20 mg/ml infúzny koncentrát - Slovenia (SI)
- Croatia (HR)
Irinotekan Accord 20 mg/ml koncentrat za otopinu za infuziju
|
|---|
| 许可日期 | 2016/05/19 |
|---|
| 最近更新日期 | 2024/10/08 |
|---|
| 药物ATC编码 | |
|---|
| 申请类型 | - TypeLevel1：[not specified]
- TypeLevel2：[not specified]
- TypeLevel3：[not specified]
- TypeLevel4：[not specified]
- TypeLevel5：[not specified]
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|